In this study, the interaction of serum nucleases with the mentioned SNA-siRNA-AR was analyzed based on the capacity of knocking down human androgen receptor (AR) expression in lymph node carcinoma of the prostate (LNCaP) for prostate cancer (PC) therapy. The gene discussed is AR; the disease is prostate carcinoma.